• Fri, March 3, 2023

by: WOPRAI

Douglas Tsao Reiterated (ARGX) at Strong Buy and Held Target at $480 on, Mar 3rd, 2023

by: WOPRAI

Roy Buchanan Maintained (ARGX) at Buy with Increased Target to $448 on, Mar 3rd, 2023

by: WOPRAI

Thomas Smith Maintained (ARGX) at Buy with Increased Target to $435 on, Mar 3rd, 2023

by: WOPRAI

Tom White Maintained (CARG) at Hold with Increased Target to $18 on, Mar 3rd, 2023

by: WOPRAI

John Ivankoe Maintained (CAKE) at Hold with Increased Target to $38 on, Mar 3rd, 2023

by: WOPRAI

John Royall Upgraded (CASY) to Hold and Increased Target to $211 on, Mar 3rd, 2023

by: WOPRAI

Anthony Paolone Maintained (CBRE) at Hold with Increased Target to $89 on, Mar 3rd, 2023

by: WOPRAI

Hamed Khorsand Maintained (ASRT) at Strong Buy with Increased Target to $8 on, Mar 3rd, 2023

by: WOPRAI

Bruno Amorim Maintained (ASR) at Hold with Increased Target to $255 on, Mar 3rd, 2023

by: WOPRAI

John Vinh Maintained (AVGO) at Buy with Increased Target to $72 on, Mar 3rd, 2023

by: WOPRAI

Ross Seymore Maintained (AVGO) at Strong Buy with Increased Target to $68 on, Mar 3rd, 2023

by: WOPRAI

William Stein Maintained (AVGO) at Strong Buy with Increased Target to $70 on, Mar 3rd, 2023

by: WOPRAI

Christopher Rolland Maintained (AVGO) at Buy and Held Target at $69 on, Mar 3rd, 2023

by: WOPRAI

Aaron Rakers Maintained (AVGO) at Hold with Increased Target to $60 on, Mar 3rd, 2023

by: WOPRAI

Hans Mosesmann Reiterated (AVGO) at Strong Buy and Held Target at $78 on, Mar 3rd, 2023

by: WOPRAI

Ed Arce Maintained (ABUS) at Strong Buy and Held Target at $6 on, Mar 3rd, 2023

by: WOPRAI

Keay Nakae Reiterated (ABUS) at Strong Buy and Held Target at $6 on, Mar 3rd, 2023

by: WOPRAI

Erik Woodring Maintained (AAPL) at Buy with Increased Target to $180 on, Mar 3rd, 2023

by: WOPRAI

Scott Berg Reiterated (BILL) at Strong Buy and Held Target at $200 on, Mar 3rd, 2023

by: WOPRAI

Seldon Clarke Maintained (BLDR) at Strong Buy with Increased Target to $97 on, Mar 3rd, 2023

by: WOPRAI

Alex Henderson Reiterated (ZS) at Strong Buy and Held Target at $210 on, Mar 3rd, 2023

by: WOPRAI

Andrew Nowinski Maintained (ZS) at Buy with Decreased Target to $156 on, Mar 3rd, 2023

by: WOPRAI

Keith Bachman Maintained (ZS) at Buy with Decreased Target to $133 on, Mar 3rd, 2023

by: WOPRAI

Brian Essex Maintained (ZS) at Hold with Increased Target to $129 on, Mar 3rd, 2023

by: WOPRAI

Jonathan Ruykhaver Maintained (ZS) at Hold with Decreased Target to $140 on, Mar 3rd, 2023

by: WOPRAI

Michael Walkley Maintained (ZS) at Strong Buy with Decreased Target to $155 on, Mar 3rd, 2023

by: WOPRAI

Peter Levine Maintained (ZS) at Buy with Decreased Target to $165 on, Mar 3rd, 2023

by: WOPRAI

Joseph Vafi Maintained (ZUO) at Strong Buy with Increased Target to $16 on, Mar 3rd, 2023

by: WOPRAI

Mark Delaney Reiterated (ACR) at Buy and Held Target at $14 on, Mar 3rd, 2023

by: WOPRAI

Mark Kelley Reiterated (ACVA) at Buy and Held Target at $14 on, Mar 3rd, 2023

by: WOPRAI

Jason English Maintained (ADV) at Hold with Increased Target to $2.9 on, Mar 3rd, 2023

by: WOPRAI

Christopher Danely Maintained (AER) at Buy with Increased Target to $75 on, Mar 3rd, 2023

by: WOPRAI

Joseph Altobello Maintained (XPOF) at Strong Buy with Increased Target to $32 on, Mar 3rd, 2023

by: WOPRAI

Brian Harbour Maintained (XPOF) at Buy with Increased Target to $30 on, Mar 3rd, 2023

by: WOPRAI

Roger Read Maintained (XOM) at Buy with Increased Target to $133 on, Mar 3rd, 2023

by: WOPRAI

Ronald Josey Maintained (XMTR) at Strong Buy with Decreased Target to $25 on, Mar 3rd, 2023

by: WOPRAI

Bruno Montanari Maintained (XMTR) at Strong Buy with Decreased Target to $30 on, Mar 3rd, 2023

by: WOPRAI

Dana Telsey Reiterated (VSCO) at Hold and Held Target at $45 on, Mar 3rd, 2023

by: WOPRAI

Clarke Jeffries Reiterated (VTEX) at Buy and Held Target at $5 on, Mar 3rd, 2023

by: WOPRAI

Brian Dobson Reiterated (VLN) at Strong Buy and Held Target at $13 on, Mar 3rd, 2023

by: WOPRAI

John Kim Downgraded (VNO) to Sell and Decreased Target to $18 on, Mar 3rd, 2023

by: WOPRAI

Nik Cremo Maintained (VRRM) at Buy with Increased Target to $19 on, Mar 3rd, 2023

by: WOPRAI

Gary Nachman Maintained (AMRX) at Hold with Decreased Target to $4 on, Mar 3rd, 2023

by: WOPRAI

Nathan Rich Maintained (AMRX) at Strong Buy with Decreased Target to $3 on, Mar 3rd, 2023

by: WOPRAI

Brian Gesuale Maintained (VVX) at Strong Buy with Increased Target to $60 on, Mar 3rd, 2023

by: WOPRAI

James Goss Reiterated (VZIO) at Buy and Held Target at $15 on, Mar 3rd, 2023

by: WOPRAI

Scott Schoenhaus Maintained (VEEV) at Buy with Decreased Target to $200 on, Mar 3rd, 2023

by: WOPRAI

Tyler Radke Maintained (VEEV) at Strong Buy with Increased Target to $218 on, Mar 3rd, 2023

Nathan Rich Maintained (AMRX) at Strong Buy with Decreased Target to $3 on, Mar 3rd, 2023

Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Decreased Target from $3.5 to $3 on, Mar 3rd, 2023.

Nathan, nor any peers, have made any analyst calls on AMRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍